# Janux Therapeutics, Inc.: Form SC 13D/A, filed Oct 22, 2024

- Company: [Janux Therapeutics, Inc.](/companies/janx.md) (CIK 1817713)
- Form: SC 13D/A
- Filed: 2024-10-22
- Accepted by EDGAR: Oct 22, 2024, 16:17 ET
- Period: not reported
- Accession: 0001104659-24-110569
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1817713/000110465924110569/tm2426608d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817713/000110465924110569/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817713/000110465924110569/tm2426608d1_sc13da.htm

Filed Oct 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-110569. Last ingested by Listed: Nov 5, 2026, 18:20 ET. No prices; not investment advice.